Gender specific cancer risks for sites other than breast and ovary in BRCA2 mutation carriers
| ICD | Location | Obs | Exp | RR | 95% CI | Pa (n) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| See Methods section for estimating RR. Obs, observed, exp, expected. | ||||||||||||
| Male | All | 139 | 117.7 | 1.4 | 1.1 to 1.6 | 57 | ||||||
| 146–149 | Pharynx | 3 | 0.8 | 6.7 | 1.4 to 19.7 | 1 | ||||||
| 150–159 | Digestive system | 37 | 29.6 | 1.5 | 1.1 to 2.1 | 17 | ||||||
| 155 | Liver | 4 | 0.7 | 11.1 | 3.0 to 28.5 | 2 | ||||||
| 157 | Pancreas | 11 | 2.5 | 7.8 | 3.9 to 14.0 | 6 | ||||||
| 170 | Bones | 2 | 0.3 | 15.0 | 1.7 to 54.3 | 1 | ||||||
| 179–189 | Urogenital system | 34 | 25.2 | 1.7 | 1.2 to 2.4 | 14 | ||||||
| 185 | Prostate | 24 | 13.6 | 2.5 | 1.6 to 3.8 | 7 | ||||||
| Female | All | 60 | 82.3 | 0.3 | 0.3 to 0.4 | 27 | ||||||
| 157 | Pancreas | 4 | 1.9 | 3.7 | 1.0 to 9.4 | 1 | ||||||